Article
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
Brain : a journal of neurology - 1 Jun 2005
Turner M R, Hammers A, Al-Chalabi A, Shaw C E, Andersen P M, Brooks D J, Leigh P N
Abstract excerpt
Five to ten percent of amyotrophic lateral sclerosis (ALS) cases are associated with mutations of the superoxide dismutase-1 (SOD1) gene, and the 'D90A' mutation is associated with a unique phenotype and markedly slower disease progression (mean survival time 14 years). Relative sparing of inhibitory cortical neuronal circuits might be one mechanism contributing to the slower progression in patients homozygous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
